High-grade Ductal Carcinoma In Situ (DCIS) of the Male Breast Treated with Breast Conserving Therapy

Rebekah Young, Kimberly Gergelis, Shalom Kalnicki and Jana L. Fox

Department of Radiation Oncology, Einstein/Montefiore Center for Cancer Care, USA
The Ohio State University, The James Cancer Center/Stefanie Spielman Comprehensive Breast Center, USA
Albert Einstein College of Medicine, USA

^*Correspondance to: Rebekah Young 

 PDF  Full Text Case Report | Open Access

Abstract:

Ductal carcinoma in situ (DCIS) is a rare diagnosis in a man, and rarer still is the detection of a high grade in situ lesion. The surgical management of both invasive breast cancer and DCIS in men is typically mastectomy. We report the case of a 61 year-old man who presented with a right-sided breast mass. The abnormality was appreciated by his primary physician, and she also palpated a left-sided nodule. Subsequent bilateral diagnostic mammogram and ultrasound showed no abnormalities on the right, but did reveal a suspicious sub-centimeter lesion in the upper inner quadrant of the left breast. Biopsy showed high grade DCIS. He underwent lumpectomy followed by adjuvant radiotherapy (RT) to the whole left breast. He tolerated surgery and RT well and has no evidence of disease and good cosmesis at 20 months follow-up. Much is known about both invasive and in situ breast disease in women, including risk factors, distribution of sub-types, and treatment options. The same cannot be said for male DCIS. In this case, we discuss the differences in male and female DCIS, as well as disparities in surgical management.

Keywords:

Male breast cancer; Male DCIS; Ductal carcinoma in situ; Breast conserving therapy

Cite the Article:

Young R, Gergelis K, Kalnicki S, Fox JL. High-grade Ductal Carcinoma In Situ (DCIS) of the Male Breast Treated with Breast Conserving Therapy. Ann Clin Case Rep. 2017; 2: 1383.